Clinical Trial Update: A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus. [Phase 1]

View source ↗

Summary

The study updates the completion of a Phase 1 multiple ascending dose trial evaluating R1511 in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• R1511

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED